Noguchi H. Recent advances in stem cell research for the treat- ment of diabetes. World J Stem Cells 2009;1:36-42.Noguchi H (2009) Recent advances in stem cell research for the treatment of diabetes. World J Stem Cells 1: 36-42.Noguchi, H. (2009). Recent advances in stem cell ...
Stem cell therapy for the spinal cord Recent advances in stem cell technologies have opened up a new avenue for the treatment of spinal cord disease and injury. Stem cells have proven ... EM Donnelly,J Lamanna,NM Boulis - 《Stem Cell Research & Therapy》 被引量: 80发表: 2012年 Advances...
Recent patents in stem cell researchPresents information on patents on stem cell research. Subject of the research; Name of assignee; Status.doi:10.1038/7957Nature Biotechnology
Thus, interest in the potential of stem cell-based therapies has been increasing considerably in recent years. The initial proposed use of stem cells as a therapy for ALS stemmed from the possibility of MN replacement and considered several stem cell types. All stem cells possess the capacity ...
The controlled and sustained release of drugs from nanocarriers ensures optimal drug concentration at the target site, maximizing therapeutic benefits. The nano-size agents can be obtained using several types of matrixes (inorganic, metal, polymeric, lipid, surfactant) and various supra-molecular ...
我来说两句 短评 ··· 热门 还没人写过短评呢 我要写书评 Recent Controversies in Stem Cell Research的书评 ··· ( 全部0 条 ) 论坛 ··· 在这本书的论坛里发言 + 加入购书单 谁读这本书? ··· 二手市场 ··· 在豆瓣转让 手里有一本闲着? 订阅关于Recent Controversies in ...
First, the regenerative benefits of the GTR treatment vary from case to case [22]. Many factors, such as diabetes, smoking, dental plaque control, tooth anatomy and morphology, affect the results of the GTR treatment [6,7]. Therefore, the outcomes of GTR treatment in clinical practice may ...
These methods’ benefits and drawbacks are also discussed. One of them, positive selection by phosphomannose isomerase (PMI) system of different plants, has been optimized and subjected to full risk assessment and is more productive than conventional protocols that employ ARMGs. This information will...
These stem cells avoid the exaggerated immune response, control acute pulmonary inflammation and repair the damaged tissues (Abreu et al. 2011; Silva et al. 2018). A clinical trial (NCT04252118) of COVID-19 stem cell therapy sponsored by Beijing Hospital is under way at the time of writing...
However, despite improvements in progression-free survival (PFS), a substantial number of patients receive minimal benefits from immune checkpoint inhibitors (ICIs). In addition, ICIs are also associated with a high incidence of treatment-related adverse events [7], [8], [9]. The sub-optimal ...